Regdanvimab clinical trials
Also written CT-P59.
How each study uses regdanvimab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- 12 Nov 2021 · Regkirona · EMEA/H/C/005854 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses regdanvimab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 InfectionCompletedPhase 2/3CelltrionNCT04602000Written as CT-P59
- This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)CompletedPhase 1CelltrionNCT04593641Written as CT-P59
- To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy SubjectsCompletedPhase 1CelltrionNCT04525079Written as CT-P59
As the comparator · 1 — what is tested is compared with regdanvimab
Codes
What other systems call regdanvimab · ClinicalTrials.gg INT001613
- MeSH (NLM) C000716788regdanvimabOne source NLM
- UNII (FDA) I0BGE6P6I6REGDANVIMABConfirmed FDA, NLM, Wikidata
- Wikidata Q105687595regdanvimabConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C177084RegdanvimabOne source FDA
- DrugBank DB16405One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000716788 | regdanvimab | One source NLM |
| UNII (FDA) | I0BGE6P6I6 | REGDANVIMAB | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q105687595 | regdanvimab | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C177084 | Regdanvimab | One source FDA |
| DrugBank | DB16405 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.